Total Funding
85
91
Total FundingPost-IPO Debt raised
Growth Score
5 pts
Heat Score
33 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
984
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
- Jeff Hartness: Chief Commercial Officer
- Jane Pritchett Henderson: Chief Financial OfficerPast Role: Kolltan Pharmaceuticals, Senior Vice President & Chief Financial and Business Officer
About the Company
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs.
Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
